HomeCompareMALRY vs MRK

MALRY vs MRK: Dividend Comparison 2026

MALRY yields 1.55% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $37.8K in total portfolio value
10 years
MALRY
MALRY
● Live price
1.55%
Share price
$37.48
Annual div
$0.58
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$19.9K
Annual income
$0.15
Full MALRY calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — MALRY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMALRYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MALRY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MALRY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MALRY
Annual income on $10K today (after 15% tax)
$131.54/yr
After 10yr DRIP, annual income (after tax)
$0.13/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, MRK beats the other by $8,596.59/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MALRY + MRK for your $10,000?

MALRY: 50%MRK: 50%
100% MRK50/50100% MALRY
Portfolio after 10yr
$38.8K
Annual income
$5,056.97/yr
Blended yield
13.02%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MALRY
Analyst Ratings
1
Hold
Consensus: Hold
Altman Z
2.0
Piotroski
3/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MALRY buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMALRYMRK
Forward yield1.55%2.81%
Annual dividend / share$0.58$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$19.9K$57.7K
Annual income after 10y$0.15$10,113.78
Total dividends collected$155.00$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: MALRY vs MRK ($10,000, DRIP)

YearMALRY PortfolioMALRY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,777$77.37$11,213$373.04$436.00MRK
2$11,571$38.97$12,667$512.06$1.1KMRK
3$12,400$19.55$14,439$708.14$2.0KMRK
4$13,278$9.79$16,640$988.16$3.4KMRK
5$14,212$4.90$19,432$1,394.07$5.2KMRK
6$15,210$2.45$23,057$1,992.90$7.8KMRK
7$16,276$1.23$27,889$2,894.79$11.6KMRK
8$17,416$0.61$34,518$4,286.29$17.1KMRK
9$18,635$0.31$43,912$6,494.35$25.3KMRK
10$19,940$0.15$57,714$10,113.78$37.8KMRK

MALRY vs MRK: Complete Analysis 2026

MALRYStock

Mineral Resources Limited, together with subsidiaries, operates as a mining services and processing company in Australia, China, and Singapore. It operates through three segments: Mining Services, Commodities, and Central. The company offers contract crushing, screening, processing, and specialist mining services; mine services, including materials handling, plant and equipment hire, plant and equipment maintenance, tails recovery, and aggregate crushing; and design, engineering, and construction services in the resources sector. It also manages the processing, production, logistics, ship loading, marketing, and export of resource commodities on behalf of tenement owners; and provides specialist parts to the mining, quarrying, and recycling industries. In addition, the company has a portfolio of iron ore assets; and owns interests in the Mount Marion and Wodgina lithium projects located in Western Australia. The company was founded in 1993 and is based in Osborne Park, Australia.

Full MALRY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MALRY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MALRY vs SCHDMALRY vs JEPIMALRY vs OMALRY vs KOMALRY vs MAINMALRY vs JNJMALRY vs ABBVMALRY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.